TS
Thangavel Santosh Kumar
About Thangavel Santosh Kumar
Data last updated:
Thangavel Santosh Kumar is a Director at Spectrax Medcenter For Analytical Research & Training Private Limited (since 2023). The company operates in Healthcare. Spectrax Medcenter For Analytical Research & Training Private Limited reported revenue of ₹9.55 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Spectrax Medcenter For Analytical Research & Training Private Limited U86201KL2023PTC081688 | Director | 29 May 2023 | 2023 | ₹9.55 Cr (FY 2025) | Active |
Board colleagues of Thangavel Santosh Kumar
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Thangavel Santosh Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Thangavel Santosh Kumar
Thangavel Santosh Kumar currently holds 1 directorship: Spectrax Medcenter For Analytical Research & Training Private Limited (Director, since 29 May 2023, revenue ₹9.55 Cr (FY 2025)).
Thangavel Santosh Kumar was first appointed on 29 May 2023 as Director at Spectrax Medcenter For Analytical Research & Training Private Limited.
The current boards of Thangavel Santosh Kumar's companies include Jacob Paulraj Vimal (Spectrax Medcenter For Analytical Research & Training Private Limited), Kumarapillai Parameswaran Srinivasakumar (Spectrax Medcenter For Analytical Research & Training Private Limited), Nigith Premachandran Nair Valsalakumari (Spectrax Medcenter For Analytical Research & Training Private Limited), Rajakumar (Spectrax Medcenter For Analytical Research & Training Private Limited), Samji (Spectrax Medcenter For Analytical Research & Training Private Limited), Thankayyan Chandra Das (Spectrax Medcenter For Analytical Research & Training Private Limited).